We had an insightful day hearing about the future of UK life sciences regulation at the BIA’s flagship annual Life Sciences Regulatory...

On 5 November 2024, Acadia Pharmaceuticals Inc. ("Acadia") announced that it sold its rare paediatric disease priority review voucher...

The MHRA has provided more information on its plans for rolling-out its new medical device framework. It aims to publish its additional...

Last week, the European Parliament (EP) passed a resolution calling on the European Commission (EC) to further revise the Medica Devices...

On 25 September 2024, the MHRA updated its roll-out of the new medical device regulatory framework for Great Britain. The MHRA aims to...

TEAM-NB has published a new version (v5.0) of its Code of Conduct for Notified Bodies. While we don’t normally comment on this Code,...

The ABPI and the Prescription Medicines Code of Practice Authority (PMCPA) have announced the release of the latest edition of the ABPI...

This article was first published in EPLAW blog [August, 2024]. Patents Court finds Janssen Biotech’s patent, for the antibody ustekinumab...

Numerous parallels can be drawn between the EU AI Act and product safety legislation - including risk classification for product...

Last week, Adam Coughlin and Luca Cericola from Bristows’ Commercial IP team attended ON Helix 2024, an annual conference hosted by One...

“To ensure available lab space scales to meet the ambitions of our fast-growing research-intensive industries, not least the life...

An AI system is classified as “high-risk”, the AI Act imposes significant requirements on the provider in order for it to place the...